Enzyme-linked immunosorbent assay (ELISA) was performed according to manufacturer’s protocol to quantify myeloperoxidase (MPO) (Abcam,
ab119605), lactoferrin (Abcam,
ab108882) and elastase levels (Abcam,
ab119553) in plasma from healthy donors, non-COVID-19 ARDS, COVID-19 patients and cell media supernatant of resiquimod treated NDN cultures from healthy donors (15 μM, Sigma-Aldrich). Briefly, a standard curve with known concentrations of the corresponding enzymes was generated to obtain their equivalent optical densities in a colorimetric assay. The concentration of the relevant enzymes in each sample was inferred from their optical densities by using the standard curve.
Reyes L., A. Sanchez-Garcia M., Morrison T., Howden A.J., Watts E.R., Arienti S., Sadiku P., Coelho P., Mirchandani A.S., Zhang A., Hope D., Clark S.K., Singleton J., Johnston S., Grecian R., Poon A., McNamara S., Harper I., Fourman M.H., Brenes A.J., Pathak S., Lloyd A., Blanco G.R., von Kriegsheim A., Ghesquiere B., Vermaelen W., Cologna C.T., Dhaliwal K., Hirani N., Dockrell D.H., Whyte M.K., Griffith D., Cantrell D.A, & Walmsley S.R. (2021). A type I IFN, prothrombotic hyperinflammatory neutrophil signature is distinct for COVID-19 ARDS. Wellcome Open Research, 6, 38.